A 7-Year History of Necrobiotic Xanthogranuloma following Asymptomatic Multiple Myeloma: A Case Report-Reference-Cited by-同舟云学术

A 7-Year History of Necrobiotic Xanthogranuloma following Asymptomatic Multiple Myeloma: A Case Report

Published:2011 Issue: Volume:2011 Page:1-5
ISSN:1687-6105
Container-title:Dermatology Research and Practice
language:en
Short-container-title:Dermatology Research and Practice

Author:

Inthasotti Siriluk¹,Wanitphakdeedecha Rungsima¹^ORCID,Manonukul Jane²

Affiliation:

1. Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

2. Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

Abstract

Necrobiotic xanthogranuloma (NXG) is a rare destructive xanthomatous granuloma with chronic, indolent, and progressive course. The morbidity and mortality are the results from wound complications and associated disorders. Because of its strong association with monoclonal gammopathy and multiple myeloma, early recognition of disease is mandatory to monitor and prevent systemic involvements of hematologic malignancies.

Publisher

Hindawi Limited

Subject

Dermatology

Link

http://downloads.hindawi.com/journals/drp/2011/927852.pdf

Reference29 articles.

1. Necrobiotic Xanthogranuloma

2. Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvement

3. Values Listed in Incorrect Columns

4. Necrobiotic Xanthogranuloma

5. Necrobiotic Xanthogranuloma with Paraproteinemia

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Histiocytoses;Rook's Textbook of Dermatology;2024-03-19

2. Bilateral vestibulopathy and sensorineural hearing loss in necrobiotic xanthogranuloma, multiple myeloma and amiloidosis;Russian Bulletin of Otorhinolaryngology;2024

3. Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment;Frontiers in Immunology;2022-11-23

4. Cutaneous manifestations of monoclonal gammopathy;Blood Cancer Journal;2022-04-11

5. Efficacy of Topical Use Crisaborole 2% Ointment for Treatment of Necrobiotic Xanthogranuloma Associated With Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2020-08